
- /
- Supported exchanges
- / US
- / ACON.NASDAQ
Aclarion Inc (ACON NASDAQ) stock market data APIs
Aclarion Inc Financial Data Overview
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Aclarion Inc data using free add-ons & libraries
Get Aclarion Inc Fundamental Data
Aclarion Inc Fundamental data includes:
- Net Revenue: 54 601
- EBITDA: -5 526 468
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-09
- EPS/Forecast: -0.17
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aclarion Inc News

Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery
(RTTNews) - Aclarion, Inc. (ACON), a healthcare technology firm, has announced the enrollment of the first patient in its CLARITY trial. The study aims to evaluate the clinical and economic value of ...


Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (Aclarion or the Company) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary au...

Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size i...

Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?
Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial partnership with Scripps Health in San Diego, CA. This agreement will introduce Noc...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.